Table 2.
Association of MST3 expression level with clinical pathological variables
| Clinical Variables | MST3 < 150 (n = 58) | MST3 ≥ 150 (n = 43) | P value |
|---|---|---|---|
| Sex | |||
| Male | 32 | 31 | 0.08 |
| Female | 26 | 12 | |
| Age | |||
| < 65 | 29 | 14 | 0.08 |
| ≥ 65 | 29 | 29 | |
| Number of Lesion | |||
| Single | 58 | 40 | 0.041* |
| Two | 0 | 3 | |
| Number of Tumor Site | |||
| Single | 57 | 38 | 0.037* |
| Multiple | 1 | 5 | |
| Tumor Configuration | |||
| Early | 13 | 3 | 0.036* |
| Advanced | 45 | 40 | |
| Histologic type | |||
| Tubular/well-differentiated | 4 | 4 | |
| Tubular/moderately-differentiated | 17 | 18 | 0.476 |
| Tubular/poorly-differentiated | 18 | 13 | |
| Signet ring | 11 | 5 | |
| Mucinous | 2 | 2 | |
| Mixed | 6 | 1 | |
| Stage | |||
| I | 19 | 10 | 0.479 |
| II | 11 | 12 | |
| III | 17 | 10 | |
| IV | 11 | 11 | |
| Lymph node metastasis | |||
| Yes | 32 | 29 | 0.213 |
| No | 26 | 14 | |
| Perineural invasion | |||
| Yes | 25 | 21 | 0.567 |
| No | 33 | 22 | |
| Depth of invasion: serosa invasion | |||
| Yes | 28 | 18 | 0.522 |
| No | 30 | 25 | |
| Tumor size (cm) | |||
| Average | 4.907 | 4.572 | 0.541 |
| Median | 4.5 | 4 | |
| Max | 14 | 9 | |
| Min | 0.5 | 1 |
n = number of patients;
*
P value < 0.05.